Regenerative Women's Health at Solo Clinic: Science, Evidence, and Honest Expectations

Regenerative medicine — the use of biological materials, growth factors, and cellular therapies to restore or enhance the body's own repair capacity — is one of the most exciting frontiers in women's health and reproductive medicine. At Solo Clinic, regenerative approaches are offered selectively — where the evidence is credible and the clinical need is real — alongside our core IVF, surgical, and obstetric practice.

But the excitement surrounding regenerative medicine is also accompanied by significant hype. For every evidence-supported application, there are several commercially marketed procedures with little scientific basis. Understanding the difference — knowing which regenerative approaches have genuine clinical value, which are still experimental but promising, and which are premature or speculative — is the most important thing any patient can bring to this conversation.

This guide provides an honest, evidence-graded overview of the major regenerative and integrative approaches in women's reproductive health, so you can make informed decisions rather than choices driven by marketing.

What Is Regenerative Medicine in the Context of Women's Health?

Regenerative medicine covers a broad spectrum of approaches that share a common goal: using biological agents — derived from the patient's own body or from natural compounds — to support the repair, regeneration, or optimisation of tissue and cellular function. In women's reproductive health, the most relevant applications include:

• Platelet-rich plasma (PRP): Concentrated platelets from the patient's own blood, rich in growth factors that stimulate cellular repair and angiogenesis.
• Stem cell therapies: Using the body's own stem cells — from bone marrow, adipose tissue, or the ovarian/endometrial tissue itself — to regenerate damaged structures.
• Nutraceutical support: Evidence-based nutritional supplements (CoQ10, vitamin D, antioxidants, DHEA) that support cellular health and reproductive function.
• Lifestyle and integrative medicine: Dietary optimisation, exercise, stress management, and sleep — the most accessible and often most impactful "integrative" interventions.

Applying an Evidence Framework

Not all regenerative approaches are equally supported by evidence. At Solo Clinic, we apply a tiered evidence framework before recommending any intervention:

• Tier 1 — Well-evidenced, standard adjunct: Evidence from multiple randomised controlled trials and meta-analyses. Offered routinely as part of standard care for appropriate patients. Example: Vitamin D supplementation for deficient patients.
• Tier 2 — Emerging evidence, selective use: Promising evidence from smaller controlled trials, with a credible biological rationale. Offered selectively when standard treatment has failed and clinical need is clear, with full transparency about evidence quality. Example: Intrauterine PRP for thin endometrium.
• Tier 3 — Investigational: Evidence from case series and preliminary studies. Offered within research or ethics committee-approved frameworks, with full patient disclosure of experimental status. Example: Intraovarian PRP for premature ovarian insufficiency.
• Not recommended: Marketed widely without credible evidence, or with evidence contradicted by higher-quality studies.

The Well-Evidenced: Nutraceuticals and Lifestyle

CoQ10 and Mitochondrial Support

Coenzyme Q10 in its ubiquinol form (200 to 600 mg/day) has the strongest evidence of any supplement for improving egg quality in women over 35 or with diminished ovarian reserve. CoQ10 supports mitochondrial energy production in egg cells — directly relevant to the chromosome segregation process that determines whether eggs are chromosomally normal. Multiple randomised trials show improved clinical pregnancy rates and embryo development metrics in women taking CoQ10 before IVF. This is Tier 1 for women over 35 or with DOR.

Vitamin D

Vitamin D deficiency affects an estimated 70 to 90% of the Indian population. Deficiency is associated with impaired ovarian function, reduced IVF success rates, higher miscarriage rates, and adverse pregnancy outcomes including gestational diabetes and pre-eclampsia. Supplementation to achieve adequate serum levels (above 30 ng/ml) is low-cost, safe, and evidence-supported. This is Tier 1 across virtually the entire patient population.

Antioxidant Therapy for Male Fertility

Sperm DNA fragmentation — one of the most important and most overlooked causes of IVF failure and recurrent miscarriage — is driven primarily by oxidative stress. A targeted antioxidant regimen (vitamin C, vitamin E, CoQ10, zinc, selenium, lycopene) reduces DFI and improves sperm parameters over 3 to 6 months. This is Tier 1 for men with elevated DFI or poor semen parameters.

DHEA for Poor Responders

Dehydroepiandrosterone (DHEA) supplementation (25 to 75 mg/day) for 3 to 6 months before IVF is used in women with diminished ovarian reserve who are anticipated poor responders. Multiple studies suggest improved ovarian response (higher egg numbers, better quality), higher live birth rates, and reduced chromosomal abnormality rates in retrieved eggs. The mechanism involves DHEA conversion to androgens that support follicle development. This is Tier 2 — offered selectively for DOR patients.

The Emerging: PRP Applications

Intrauterine PRP for Thin Endometrium

For women whose endometrium persistently fails to reach adequate thickness (7 mm) despite optimised oestrogen preparation, intrauterine PRP infusion — instilling concentrated platelet-rich plasma into the uterine cavity — offers a low-risk, biologically credible intervention. Platelets release growth factors (VEGF, EGF, PDGF, TGF-β) that promote endometrial proliferation and angiogenesis. Several prospective studies and RCTs report meaningful improvements in endometrial thickness and clinical pregnancy rates in refractory thin endometrium. This is Tier 2 — offered when standard protocols have failed.

Intraovarian PRP

Injection of PRP directly into the ovarian cortex — aimed at activating dormant primordial follicles in women with severely diminished reserve or early premature ovarian insufficiency — is an area of active research. Case series and small controlled studies report improvements in AMH and antral follicle count in some patients, with live births documented in women with previously undetectable AMH. This is Tier 3 — investigational, offered only in appropriate patients with full informed consent about experimental status.

The Investigational: Stem Cell Therapies

Stem cell applications in reproductive medicine represent the most exciting and most carefully regulated frontier at Solo Clinic. The landmark achievements that define our position in this field:

• India's first stem cell baby — achieved at Solo Clinic under Dr. Tandulwadkar's leadership
• World's first stem cell-assisted conception in a 45-year-old woman — a first for both India and the world

These achievements were accomplished within appropriate scientific and ethical frameworks — not as commercial procedures offered to all comers. Stem cell applications in fertility medicine are Tier 3: genuinely promising, clinically demonstrated in selected cases, but not ready for universal clinical adoption.

Current investigational applications include stem cell-assisted ovarian rejuvenation for premature ovarian insufficiency, endometrial stem cell therapy for Asherman's syndrome and refractory thin endometrium, and mitochondrial support technologies for age-related egg quality decline.

What Solo Clinic Does Not Offer

Equally important to what we offer is what we do not. We do not:

• Offer intraovarian PRP or stem cell treatments as standard, universally recommended procedures
• Guarantee outcomes from any regenerative intervention
• Offer commercially marketed "fertility rejuvenation" packages without a credible evidence base
• Use regenerative procedures as a substitute for honest clinical counselling — including candid discussion of when donor egg IVF or other alternatives may offer better probability outcomes

Frequently Asked Questions

Q1. How do I know if a regenerative treatment being offered to me is legitimate?

Ask three questions: (1) What published peer-reviewed evidence supports this specific application? (2) What success rates has this clinic documented in their own patient population, measured as live births? (3) Is this offered as a standard treatment or within a research framework? Legitimate clinics will answer these questions clearly. Be cautious of: guaranteed outcomes, "proprietary" protocols whose ingredients are not disclosed, and pressure to commit to expensive packages before a baseline clinical assessment.

Q2. Are regenerative treatments covered by insurance in India?

No — regenerative fertility treatments (PRP, DHEA, stem cell procedures) are not covered under standard Indian health insurance policies. They are paid out-of-pocket. The cost varies widely; a detailed written cost estimate before committing to any procedure is essential.

Q3. I have read about "ovarian rejuvenation" online. Is this the same as what Solo Clinic offers?

The term "ovarian rejuvenation" is used commercially across a wide range of procedures with very different evidence bases — from well-designed PRP studies to unproven infusions. What Solo Clinic offers in this space is intraovarian PRP within a carefully selected, consented patient population, with honest pre-procedure counselling about the experimental nature of the intervention and realistic success probabilities. This is categorically different from commercial "rejuvenation" programmes that promise outcomes they cannot reliably deliver.

Q4. I have very low AMH. Should I try PRP before IVF?

For most women with low AMH, the most evidence-supported path remains IVF (or in some cases, direct donor egg IVF). Intraovarian PRP may be discussed as a selective option when standard IVF stimulation has produced no eggs across multiple cycles, or when AMH is undetectable and there is no other path with the patient's own eggs. The conversation about PRP should happen alongside — not instead of — honest counselling about donor egg IVF, which offers well-documented success rates of 55 to 65% per transfer at any recipient age.

Q5. Can lifestyle changes really make a meaningful difference to fertility?

Yes — in some areas, very meaningfully. Smoking cessation (for sperm DNA fragmentation and egg quality), achieving a healthy BMI (for PCOS-related ovulation restoration and IVF success rates), vitamin D supplementation (for the majority of deficient Indian patients), and CoQ10 support (for egg mitochondrial function in women over 35) are all interventions with credible evidence and real-world clinical impact. These are also the lowest-cost, lowest-risk, and most accessible regenerative interventions available — and they should always be optimised before considering more invasive or expensive procedures.